SVB Leerink Maintains Outperform on Merck & Co, Lowers Price Target to $101

SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and lowers the price target from $102 to $101.

SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and lowers the price target from $102 to $101.

Total
0
Shares
Related Posts